Name:
Borrelia mayonii Pritt et al. 2016
DSM No.:
102811, Proposed type strain dsm-102811 dsm102811 dsm 102811 Borrelia mayonii
Strain designation:
MN14-1420
Other collection no.
or WDCM no.:
ATCC BAA-2743
Isolated from:
human blood from a patient exposed to infected ticks
Country:
United States of America
Upper Midwest
Date of sampling:
08.11.2014
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- J. Petersen, CDC; MN14-1420
Genbank accession numbers:
Summary and
additional information:
<- J. Petersen, CDC; MN14-1420. Human blood from a patient exposed to infected ticks; USA, Upper Midwest. Taxonomy/description (26339). Sequence accession no. 16S rRNA gene: KP972468. (Medium 403, 30°C, microaerophilic).
Risk group:
2 (provisional classification by DSMZ)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1Material transfer agreement,
Category DCommercial use and transfer to third parties is completely excluded for this strain.
Supplied as:
| Delivery form | | Prices |
|
| actively growing culture | | 160,- € | |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
